Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Drug Candidates for the Treatment of Skin Diseases"
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 4467
Special Issue Editors
Interests: skin diseases; psoriasis; NMSC; biomarker evaluation; clinical trial monitoring; pharmaceuticals; retinoids; infective diseases; drug efficacy evaluation; statistical analysis
Interests: skin diseases; NMSC; psoriasis; melanoma; post-marketing drug surveillance, pharmaceuticals; retinoids; infective skin diseases; medical devices
Special Issue Information
This Special Issue aims to provide a comprehensive overview of the state of the art in innovative drugs for skin disease treatments.
Because it interfaces with the environment, skin plays a key role in protecting the body against pathogens and excessive water loss. Skin is also important for insulation, temperature regulation, sensation, synthesis of vitamin D, and the protection of vitamin B folates. Severely damaged skin, for exogenous or endogenous reasons, needs to be treated for the restoration of its functions.
Currently, there are several treatments for the treatment of skin diseases. In this Special Issue, the focus is on innovative treatments and on the correct comparison and/or evaluation of treatments, emphasizing the type of clinical trial or observational or prospective study used. Both in vitro and computational studies will be accepted.
The Special Issue will publish full research articles and systematic reviews that reflect current best practice in new drug candidates for the treatment of skin diseases.
Dr. Gaetana Costanza
Dr. Elena Campione
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- skin diseases
- biomarker evaluation
- clinical trial monitoring
- infective diseases
- drug efficacy evaluation
- statistical analysis